Disc Medicine, Inc.
IRON
$59.79
$0.3750.63%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -62.09% | -15.71% | -10.74% | -0.94% | 2.22% |
Total Depreciation and Amortization | 325.00% | 122.22% | -18.18% | -90.00% | 323.08% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 66.93% | 75.73% | 30.10% | -49.99% | -13.17% |
Change in Net Operating Assets | 102.46% | -2,205.42% | -106.73% | 2.79% | 166.22% |
Cash from Operations | -15.81% | -50.06% | -58.82% | -12.79% | 54.19% |
Capital Expenditure | 95.77% | -89.53% | -5,712.50% | 166.67% | 104.48% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 119.03% | -27,718.01% | 98.63% | 67.65% | -- |
Cash from Investing | 118.96% | -19,018.72% | 97.99% | 67.65% | -327,883.58% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -99.62% | 19,439.52% | 182.16% | -99.75% | 989.25% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -100.00% | 773.80% | -- | -- | -- |
Cash from Financing | -99.63% | 748.18% | 6,659.86% | -99.75% | 989.25% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 106.68% | -34,433.66% | 99.77% | -42.09% | -248.71% |